FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Hospira 5% Lidocaine HCL and 7 Recall

5% Lidocaine HCL and 7

Hospira Inc. · Lake Forest, IL

Risk level
Class III
Reported by FDA
Dec 14, 2016
Recall ID
D-0169-2017
Check your lot numberHow we source this data

Summary

Hospira recalled 5% Lidocaine HCL and 7 starting Jun 29, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0169-2017 on Dec 14, 2016. Reason: Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life. Status: Terminated.

Why it was recalled

Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.

Product description

5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01

Lot numbers, UPCs & expiration codes

Lot # 34-547-DK, 34-548-DK, Exp. 10/16, Lot # 39-372-DK, Exp. 03/17 Lot Number may be followed by numbers from 01 to 99

Where it was sold

US and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0169-2017
Classification
Class III
Status
Terminated
Recall initiated
Jun 29, 2016
FDA report date
Dec 14, 2016
Quantity
287,200 2 mL ampules
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-0169-2017, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
74720
Address
275 N Field Dr
Code information
Lot # 34-547-DK, 34-548-DK, Exp. 10/16, Lot # 39-372-DK, Exp. 03/17 Lot Number may be followed by numbers from 01 to 99
Postal code
60045-2579
Report date
Dec 14, 2016
Product type
Drugs
Recall number
D-0169-2017
Classification
Class III
Recalling firm
Hospira Inc.
Product quantity
287,200 2 mL ampules
Termination date
Nov 20, 2019
Reason for recall
Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.
Voluntary / mandated
Voluntary: Firm initiated
Product description
5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01
Distribution pattern
US and Puerto Rico
Recall initiation date
Jun 29, 2016
Initial firm notification
Letter
Center classification date
Dec 6, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0169-2017, published Dec 14, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls